NCT00794066
Completed
Not Applicable
Prevalence of Peripheral Arterial Disease in Acute Ischemic and Hemorrhagic Stroke Patients
University of Erlangen-Nürnberg Medical School1 site in 1 country1,500 target enrollmentAugust 2008
ConditionsPeripheral Artery Disease
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Peripheral Artery Disease
- Sponsor
- University of Erlangen-Nürnberg Medical School
- Enrollment
- 1500
- Locations
- 1
- Primary Endpoint
- Functional outcome (modified Rankin Scale)
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
Purpose:
To assess the prevalence of peripheral arterial disease (PAD) in acute stroke patients.
Interventions:
Assessment of the ankle brachial index using the "boso-ABI-system 100" (www.boso.de).
Design:
Prospective, open, cohort study.
Study size planned:
Follow-up duration:
3 months.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All consecutive adult patients with acute ischemic or hemorrhagic stroke.
Exclusion Criteria
- •Congestive heart failure.
Outcomes
Primary Outcomes
Functional outcome (modified Rankin Scale)
Time Frame: 3 months
Secondary Outcomes
- Prevalence of peripheral arterial disease(during hospital stay)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Etiology and Prevalence of Peripheral Arterial DiseaseCardiovascular DiseasesPeripheral Vascular DiseasesArterial Occlusive DiseasesNCT00005142National Heart, Lung, and Blood Institute (NHLBI)
Completed
Not Applicable
Prevalence of peripheral arterial disease in patients with coronary artery diseaseperipheral arterial disease (peripheral artery disease of lower limb, renal artery stenosis, carotid artery stenosis and abdominal aortic stenosis)JPRN-UMIN000002486Kokura Memorial Hospital2,000
Completed
Not Applicable
Prevalence of Peripheral Arterial Disease in Subject With a Moderate Risk of Cardiovascular (CV) Disease (CVD) in Primary PreventionPeripheral Arterial Disease (PAD)Moderate Risk for Cardiovascular Disease (CVD)NCT00689377AstraZeneca9,000
Unknown
Not Applicable
Peripheral Artery Disease and Sepsis OutcomesPeripheral Artery DiseasePeripheral Artery OcclusionSepsisDiagnosisNCT03372330National Taiwan University Hospital Hsin-Chu Branch200
Completed
Not Applicable
PAD Awareness StudyPeripheral Arterial DiseaseNCT05552079Chinese University of Hong Kong1,000